Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Diseases | 3 | 2019 | 70 | 0.600 |
Why?
|
| Kidney Neoplasms | 3 | 2015 | 75 | 0.520 |
Why?
|
| Podocytes | 4 | 2023 | 37 | 0.520 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2015 | 44 | 0.440 |
Why?
|
| Biopsy, Fine-Needle | 7 | 2013 | 63 | 0.420 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2011 | 7 | 0.370 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 25 | 0.340 |
Why?
|
| Lymphatic Metastasis | 3 | 2010 | 88 | 0.340 |
Why?
|
| Tumor Virus Infections | 1 | 2009 | 16 | 0.320 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 25 | 0.320 |
Why?
|
| Carcinosarcoma | 1 | 2006 | 4 | 0.270 |
Why?
|
| Uterine Neoplasms | 1 | 2006 | 17 | 0.260 |
Why?
|
| Adenoma | 2 | 2021 | 61 | 0.260 |
Why?
|
| Pleural Neoplasms | 1 | 2006 | 11 | 0.250 |
Why?
|
| Mesothelioma | 1 | 2006 | 14 | 0.250 |
Why?
|
| Enterocolitis | 1 | 2005 | 4 | 0.240 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 103 | 0.240 |
Why?
|
| Carcinoma, Lobular | 1 | 2005 | 23 | 0.240 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 33 | 0.240 |
Why?
|
| Candidiasis | 1 | 2005 | 23 | 0.240 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 42 | 0.240 |
Why?
|
| Humans | 23 | 2023 | 25967 | 0.230 |
Why?
|
| Colonoscopy | 2 | 2021 | 73 | 0.220 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 106 | 0.220 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 2023 | 16 | 0.210 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 402 | 0.200 |
Why?
|
| Proteinuria | 2 | 2023 | 48 | 0.200 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2015 | 40 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2021 | 14 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 1352 | 0.180 |
Why?
|
| Antibodies | 1 | 2021 | 45 | 0.180 |
Why?
|
| Female | 12 | 2019 | 14734 | 0.170 |
Why?
|
| Paraproteinemias | 1 | 2019 | 4 | 0.150 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2019 | 6 | 0.150 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2019 | 15 | 0.150 |
Why?
|
| Middle Aged | 9 | 2015 | 8772 | 0.150 |
Why?
|
| Animals | 6 | 2023 | 3503 | 0.140 |
Why?
|
| Adult | 5 | 2015 | 7662 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2019 | 125 | 0.140 |
Why?
|
| CD11b Antigen | 1 | 2017 | 16 | 0.130 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 17 | 0.130 |
Why?
|
| Receptor, ErbB-4 | 1 | 2016 | 2 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 4 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 19 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2016 | 17 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2016 | 43 | 0.130 |
Why?
|
| Macrophages | 1 | 2017 | 101 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 2 | 2006 | 52 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2016 | 168 | 0.120 |
Why?
|
| Granulomatous Mastitis | 1 | 2015 | 3 | 0.120 |
Why?
|
| Angiomyolipoma | 1 | 2015 | 3 | 0.120 |
Why?
|
| Biopsy | 3 | 2021 | 196 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 177 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2019 | 3358 | 0.110 |
Why?
|
| Male | 7 | 2017 | 14277 | 0.110 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 543 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2013 | 10 | 0.100 |
Why?
|
| Urologic Neoplasms | 1 | 2011 | 4 | 0.090 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2011 | 18 | 0.090 |
Why?
|
| Rhabdomyosarcoma | 1 | 2010 | 8 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2011 | 128 | 0.090 |
Why?
|
| Trisomy | 1 | 2010 | 3 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2010 | 6 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 24 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 36 | 0.080 |
Why?
|
| Nephrectomy | 1 | 2010 | 37 | 0.080 |
Why?
|
| Cytodiagnosis | 2 | 2010 | 18 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 174 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 135 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 54 | 0.080 |
Why?
|
| BK Virus | 1 | 2009 | 12 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 165 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2006 | 55 | 0.080 |
Why?
|
| Chondroma | 1 | 2008 | 6 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 203 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 115 | 0.070 |
Why?
|
| Chondrocytes | 1 | 2008 | 154 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 8 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2019 | 297 | 0.070 |
Why?
|
| Reed-Sternberg Cells | 1 | 2006 | 2 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 15 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 29 | 0.070 |
Why?
|
| Bronchi | 1 | 2006 | 12 | 0.070 |
Why?
|
| Carcinoma, Large Cell | 1 | 2006 | 12 | 0.070 |
Why?
|
| Hodgkin Disease | 1 | 2006 | 19 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2006 | 54 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 76 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 2006 | 3 | 0.060 |
Why?
|
| Gastric Mucosa | 1 | 2006 | 9 | 0.060 |
Why?
|
| Stomach | 1 | 2006 | 14 | 0.060 |
Why?
|
| Arteries | 1 | 2006 | 13 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2006 | 22 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 368 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 26 | 0.060 |
Why?
|
| Cadherins | 1 | 2005 | 30 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2019 | 437 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 360 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 64 | 0.060 |
Why?
|
| Aged | 4 | 2015 | 8732 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 12 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 4641 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 648 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3399 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2021 | 16 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 55 | 0.040 |
Why?
|
| Observer Variation | 1 | 2021 | 97 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 337 | 0.040 |
Why?
|
| Receptor, PAR-2 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 7 | 0.040 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2019 | 2 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 16 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 15 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 20 | 0.040 |
Why?
|
| Adipocytes | 1 | 2019 | 22 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 44 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 13 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 61 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 19 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 38 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 96 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 649 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 214 | 0.040 |
Why?
|
| Disease Management | 1 | 2019 | 101 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 297 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2017 | 2 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2017 | 5 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 9 | 0.030 |
Why?
|
| Ribonucleases | 1 | 2016 | 7 | 0.030 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 11 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 19 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 21 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 60 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 577 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 544 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 263 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 868 | 0.030 |
Why?
|
| Ultrasonography, Mammary | 1 | 2015 | 10 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2015 | 14 | 0.030 |
Why?
|
| Mammography | 1 | 2015 | 43 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 729 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2011 | 10 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 616 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 2237 | 0.020 |
Why?
|
| Chondroblastoma | 1 | 2008 | 2 | 0.020 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2008 | 3 | 0.020 |
Why?
|
| Fibroma | 1 | 2008 | 5 | 0.020 |
Why?
|
| Chondrosarcoma | 1 | 2008 | 42 | 0.020 |
Why?
|
| Adolescent | 1 | 2006 | 2099 | 0.010 |
Why?
|